Category: Joint ventures/collaborations
-
BASF, Massachusetts Universities to Partner on Materials
Researchers at the German chemical company BASF and three universities in Massachusetts will collaborate on the development of new materials for the automotive, building and construction, and energy industries. Financial details of the new five-year North American Center for Research on Advanced Materials were not disclosed, but the universities in consortium — Harvard University, MIT,…
-
Consortium to Develop Disease Model for Multiple Sclerosis
A coalition of research institutes, analytics companies, and a patient network are building computational tools and models to better understand the causes of multiple sclerosis. Orion Bionetworks, based in Boston, is a consortium of the Accelerated Cure Project for Multiple Sclerosis, Institute for Neurosciences at Brigham and Women’s Hospital, GNS Healthcare, MetaCell, and PatientsLikeMe. Orion…
-
Merck, Samsung to Collaborate on Biosimilars
The pharmaceutical company Merck & Co. in New Jersey and Samsung Bioepis Co. in Seoul, South Korea agreed on a deal for licensing and taking to market non-branded biologic therapies called biosimilars. While the companies released an outline of the financial arrangements, the dollar amount of the agreement was not disclosed. Biosimilars are treatments and…
-
Biotechs to Partner on Cancer Therapy, Drug Production
The biotechnology companies iBio Inc. in Newark, Delaware and Caliber Biotherapeutics in Bryan, Texas agreed to combine their plant-based genomic drug discovery and development technologies to produce new therapeutics, beginning with a cancer drug. Financial aspects of the deal were not disclosed. iBio’s platform, called iBio Launch, uses plant biology to harness gene expression for…
-
Lockheed Martin, Nanyang Univ. to Partner on Nanotech Copper
Lockheed Martin Corp. in Bethesda, Maryland and Singapore’s Nanyang Technological University (NTU) will collaborate on research involving a new type of copper based on nanotechnology. The laboratory established under the agreement signed today will have initial funding of $10 million over four years. The NTU-Lockheed Martin Joint Laboratory at the university’s Yunnan campus will employ…
-
Roche, Biotech to Partner on Growth Hormone Disorders
The Swiss pharmaceutical company Roche will license a compound developed by biotechnology company Chiasma Inc., based in New York and Jerusalem, to treat the hormonal disease acromegaly and neuroendocrine tumors. The deal has a total potential value to Chiasma of $595 million. Chiasma develops drugs for oral administration previously available in injection form. The company’s…
-
Smart Wall Panel Designed to Give Seniors Day-to-Day Help
University and company researchers in Germany are designing systems to be built into the walls of older peoples’ homes to help with simple day-to-day tasks as well as monitor their health. A team from Technical University Munich (Technische Universität München, TUM) will demonstrate the Living Independently in Südtirol/Alto Adige or LISA prototype on 20 February…
-
GE, Vanderbilt to Partner on Colon Cancer Research
GE Global Research, a division of General Electric Company, and Vanderbilt University’s Ingram Cancer Center in Nashville are collaborating on research to better understand the formation of colon cancer tumors at the level of individual cells. The study is funded by a five-year, $3.75 million grant from National Institutes of Health (NIH). Better cancer diagnosis…
-
Janssen R&D Opens Lab Space to Individual Entrepreneurs
Janssen Labs at San Diego, part of Janssen Research and Development and the pharmaceutical company Johnson & Johnson, is expanding its open laboratory facilities to individual life science entrepreneurs to conduct early stage research. The facility, open for a year, is already home to 18 start-up companies in the life sciences. Janssen Labs is housed…
-
3D Printing Reproduces Human Embryonic Stem Cells
Biomedical engineers at Heriot-Watt University in Edinburgh, Scotland, U.K. and the company Roslin Cellab also near Edinburgh developed a lab technique with ink-jet printing to build human embryonic stem cells. The team led by Heriot-Watt professor Will Wenmiao Shu published its findings yesterday in the journal Biofabrication (available free with regisration for 30 days). While…